top of page

Groundbreaking Medical Research at Newcastle University finds RSV vaccine safe and effective

Newcastle University
25 March 2024

This week at Newcastle University's Medical School, news broke about the success of the Moderna-sponsored ConquerRSV vaccine clinical trial – a testament to the ever-evolving landscape of healthcare and the potential impact of Newcastle's research on global health challenges.

Respiratory syncytial virus (RSV) is a common respiratory illness that typically causes mild, cold-like symptoms. However, for infants, young children, and those with compromised immune systems, RSV can lead to serious lower respiratory infections such as bronchiolitis and pneumonia.

There's currently no specific treatment for RSV, and until recently, no effective preventative vaccines were available. 

Newcastle University's Medical School offers an unparalleled opportunity to be at the forefront of medical discovery while gaining crucial clinical experience.  If you're passionate about medicine and eager to contribute to the future of healthcare, then Newcastle University is the place for you.

Ready to Learn More? Book a Consultation By Clicking The Button Below!




Consultants logo representing academic success and global education opportunities. Trust Future Graduates for expert study abroad guidance.

Omar Hussain
Managing Director, UK

+44 7947 455105

Khaled Al Abdullah
Admissions Manager, Kuwait
+965 9984 9320

Yousif Swaise

Regional Manager, Qatar


Rehan Waqar

Immigration Lawyer

0330 175 7627

  • Telegram
  • X
  • Instagram
  • Facebook

© Copyright 2023 Future Graduates Ltd. Reg No: 09448340

2nd Floor Millbank Tower, 21-24 Millbank, London, SW1P 4QP

bottom of page